{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:48:14Z","timestamp":1791910094213,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["Orden EDU\/601\/2020"],"award-info":[{"award-number":["Orden EDU\/601\/2020"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01579-8","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:23:01Z","timestamp":1784370181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-4337","authenticated-orcid":false,"given":"Oihane","family":"P\u00e9rez-Escurza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Martijn","family":"Kolijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9201-1166","authenticated-orcid":false,"given":"J\u00f3n \u00de\u00f3rir","family":"\u00d3skarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Jara-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"del Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8715-5846","authenticated-orcid":false,"given":"Quentin","family":"L\u00e9crevisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1119-4387","authenticated-orcid":false,"given":"Juan","family":"Flores-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzalba","family":"Sanoja-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edn Ruth","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5017-3530","authenticated-orcid":false,"given":"Sigr\u00fan","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e6mundur","family":"R\u00f6gnvaldsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur Jon","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2078-3220","authenticated-orcid":false,"given":"Anton W.","family":"Langerak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4964-7476","authenticated-orcid":false,"given":"Sigurdur Yngvi","family":"Kristinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-7230","authenticated-orcid":false,"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the iStopMM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ECRIN-M3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"1579_CR1","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348.","journal-title":"Lancet Oncol"},{"key":"1579_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101129","volume":"62","author":"P Kapoor","year":"2023","unstructured":"Kapoor P, Rajkumar SV. Current approach to Waldenstr\u00f6m macroglobulinemia. Blood Rev. 2023;62:101129.","journal-title":"Blood Rev"},{"key":"1579_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3816\/CLM.2009.n.002","volume":"9","author":"R Kyle","year":"2009","unstructured":"Kyle R, Benson J, Larson D, Therneau T, Dispenzieri A, Melton LJ, et al. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstr\u00f6m\u2019s macroglobulinemia. Clin Lymphoma Myeloma. 2009;9:17\u20138.","journal-title":"Clin Lymphoma Myeloma"},{"key":"1579_CR4","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99:1802\u201324.","journal-title":"Am J Hematol"},{"key":"1579_CR5","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362\u20139.","journal-title":"N Engl J Med"},{"key":"1579_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0263-z","volume":"9","author":"D Murray","year":"2019","unstructured":"Murray D, Kumar SK, Kyle RA, Dispenzieri A, Dasari S, Larson DR, et al. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement. Blood Cancer J. 2019;9:102.","journal-title":"Blood Cancer J"},{"key":"1579_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1515\/cclm-2019-1104","volume":"58","author":"KA Turner","year":"2020","unstructured":"Turner KA, Frinack JL, Ettore MW, Tate JR, Graziani MS, Jacobs JFM, et al. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis. Clin Chem Lab Med. 2020;58:533\u201346.","journal-title":"Clin Chem Lab Med"},{"key":"1579_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood-2022-163169","volume":"140","author":"TJ Love","year":"2022","unstructured":"Love TJ, R\u00f6gnvaldsson S, Thorsteinsdottir S, Aspelund T, Reed ER, Vidarsson B, et al. Prevalence of MGUS is high in the ISTOPMM study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do. Blood. 2022;140:256\u20138.","journal-title":"Blood"},{"key":"1579_CR9","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood.2021011452","volume":"138","author":"AH Bazarbachi","year":"2021","unstructured":"Bazarbachi AH, Avet-Loiseau H, Szalat R, Samur AA, Hunter Z, Shammas M, et al. IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM. Blood. 2021;138:1980\u20135.","journal-title":"Blood"},{"key":"1579_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1182\/blood-2013-05-505487","volume":"123","author":"I Turesson","year":"2014","unstructured":"Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Drayson MT, et al. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood. 2014;123:338\u201345.","journal-title":"Blood"},{"key":"1579_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70029","volume":"8","author":"DF Moreno","year":"2024","unstructured":"Moreno DF, Jim\u00e9nez C, Escalante F, Askari E, Castellanos-Alonso M, Arnao M, et al. Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: results from a Spanish multicenter registry. HemaSphere. 2024;8:e70029.","journal-title":"HemaSphere"},{"key":"1579_CR12","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","volume":"20","author":"J Hillengass","year":"2019","unstructured":"Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019;20:e302\u201312.","journal-title":"Lancet Oncol"},{"key":"1579_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cyto.b.20512","volume":"78B","author":"B Paiva","year":"2010","unstructured":"Paiva B, Almeida J, P\u00e9rez-Andr\u00e9s M, Mateo G, L\u00f3pez A, Rasillo A, et al. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders. Cytometry B Clin Cytom. 2010;78B:239\u201352.","journal-title":"Cytometry B Clin Cytom"},{"key":"1579_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cyto.b.21265","volume":"90","author":"J Flores-Montero","year":"2016","unstructured":"Flores-Montero J, de Tute R, Paiva B, Perez JJ, B\u00f6ttcher S, Wind H, et al. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma. Cytom Part B - Clin Cytom. 2016;90:61\u201372.","journal-title":"Cytom Part B - Clin Cytom"},{"key":"1579_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41375-022-01762-3","volume":"37","author":"I Dogliotti","year":"2023","unstructured":"Dogliotti I, Jim\u00e9nez C, Varettoni M, Talaulikar D, Bagratuni T, Ferrante M, et al. Diagnostics in Waldenstr\u00f6m\u2019s macroglobulinemia: a consensus statement of the European Consortium for Waldenstr\u00f6m\u2019s Macroglobulinemia. Leukemia. 2023;37:388\u201395.","journal-title":"Leukemia"},{"key":"1579_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/leu.2013.124","volume":"28","author":"B Paiva","year":"2014","unstructured":"Paiva B, Montes MC, Garc\u00eda-Sanz R, Ocio EM, Alonso J, De Las Heras N, et al. Multiparameter flow cytometry for the identification of the Waldenstr\u00f6m\u2019s clone in IgM-MGUS and Waldenstr\u00f6m\u2019s Macroglobulinemia: New criteria for differential diagnosis and risk stratification. Leukemia. 2014;28:166\u201373.","journal-title":"Leukemia"},{"key":"1579_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/17474086.2023.2270779","volume":"16","author":"R Garc\u00eda-Sanz","year":"2023","unstructured":"Garc\u00eda-Sanz R, Hunter ZR, Poulain S, Varettoni M, Owen RG. New developments in the diagnosis and characterization of Waldenstr\u00f6m\u2019s macroglobulinemia. Expert Rev Hematol. 2023;16:835\u201347.","journal-title":"Expert Rev Hematol"},{"key":"1579_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/cyto.b.22062","volume":"102","author":"N Das","year":"2022","unstructured":"Das N, Dahiya M, Gupta R, Rai S, Singh S, Prajapati VK, et al. Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern-based recognition. Cytometry B Clin Cytom. 2022;102:292\u2013302.","journal-title":"Cytometry B Clin Cytom"},{"key":"1579_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70620","volume":"29","author":"E Sourdeau","year":"2025","unstructured":"Sourdeau E, Boccon-Gibod C, Corneau A, Costopoulos M, Bravetti C, Armand M, et al. Phenotypic Profile of Waldenstr\u00f6m Macroglobulinaemia B-Cells: Establishment of a Diagnosis Scoring System and Clinico-Biological Correlations. J Cell Mol Med. 2025;29:e70620.","journal-title":"J Cell Mol Med"},{"key":"1579_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/gcc.22234","volume":"54","author":"IV Kostopoulos","year":"2015","unstructured":"Kostopoulos IV, Paterakis G, Papadimitriou K, Pavlidis D, Tsitsilonis OE, Papadhimitriou SI. Immunophenotypic analysis reveals heterogeneity and common biologic aspects in monoclonal B-cell lymphocytosis. Genes Chromosomes Cancer. 2015;54:210\u201321.","journal-title":"Genes Chromosomes Cancer"},{"key":"1579_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00480-w","volume":"11","author":"S R\u00f6gnvaldsson","year":"2021","unstructured":"R\u00f6gnvaldsson S, Love TJ, Thorsteinsdottir S, Reed ER, \u00d3skarsson J\u00de, P\u00e9tursd\u00f3ttir \u00cd, et al. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood Cancer J. 2021;11:94.","journal-title":"Blood Cancer J"},{"key":"1579_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00944-1","volume":"13","author":"O P\u00e9rez-Escurza","year":"2023","unstructured":"P\u00e9rez-Escurza O, Flores-Montero J, \u00d3skarsson J\u00de, Sanoja-Flores L, Del Pozo J, Lecrevisse Q, et al. Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study. Blood Cancer J. 2023;13:182.","journal-title":"Blood Cancer J"},{"key":"1579_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-025-01255-3","volume":"15","author":"O P\u00e9rez-Escurza","year":"2025","unstructured":"P\u00e9rez-Escurza O, Flores-Montero J, \u00d3skarsson J\u00de, Sanoja-Flores L, Pozo J, L\u00e9crevisse Q, et al. Deep immune cell profiling in blood and bone marrow of early stage monoclonal gammopathy: an iStopMM and ECRIN-M3 collaborative study. Blood Cancer J. 2025;15:1\u20135.","journal-title":"Blood Cancer J"},{"key":"1579_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-0716-2115-8_10","volume":"2453","author":"A Langlois De Septenville","year":"2022","unstructured":"Langlois De Septenville A, Boudjoghra M, Bravetti C, Armand M, Salson M, Giraud M, et al. Immunoglobulin gene mutational status assessment by next generation sequencing in chronic lymphocytic leukemia. Methods Mol Biol Clifton Nj. 2022;2453:153\u201367.","journal-title":"Methods Mol Biol Clifton Nj"},{"key":"1579_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/bioinformatics\/btw634","volume":"33","author":"V Bystry","year":"2017","unstructured":"Bystry V, Reigl T, Krejci A, Demko M, Hanakova B, Grioni A, et al. ARResT\/Interrogate: an interactive immunoprofiler for IG\/TR NGS data. Bioinforma Oxf Engl. 2017;33:435\u20137.","journal-title":"Bioinforma Oxf Engl"},{"key":"1579_CR26","first-page":"3188","volume":"5","author":"JP Stewart","year":"2021","unstructured":"Stewart JP, Gazdova J, Darzentas N, Wren D, Proszek P, Fazio G, et al. Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders. Blood Adv. 2021;5:3188\u201398.","journal-title":"Blood Adv"},{"key":"1579_CR27","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","volume":"123","author":"ZR Hunter","year":"2014","unstructured":"Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014;123:1637\u201346.","journal-title":"Blood"},{"key":"1579_CR28","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41588-025-02196-0","volume":"57","author":"JB Alberge","year":"2025","unstructured":"Alberge JB, Dutta AK, Poletti A, Coorens THH, Lightbody ED, Toenges R, et al. Genomic landscape of multiple myeloma and its precursor conditions. Nat Genet. 2025;57:1493\u2013503.","journal-title":"Nat Genet"},{"key":"1579_CR29","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","volume":"32","author":"N Bolli","year":"2018","unstructured":"Bolli N, Biancon G, Moarii M, Gimondi S, Li Y, de Philippis C, et al. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups. Leukemia. 2018;32:2604\u201316.","journal-title":"Leukemia"},{"key":"1579_CR30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1080\/10428194.2024.2313623","volume":"65","author":"S \u00d8stergaard","year":"2024","unstructured":"\u00d8stergaard S, Schejbel L, Breinholt MF, Pedersen M\u00d8, Hammer T, Munksgaard L, et al. Mutational landscape in Waldenstr\u00f6m macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice. Leuk Lymphoma. 2024;65:758\u201367.","journal-title":"Leuk Lymphoma"},{"key":"1579_CR31","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1182\/bloodadvances.2022008876","volume":"7","author":"KH Maclachlan","year":"2022","unstructured":"Maclachlan KH, Bagratuni T, Kastritis E, Ziccheddu B, Lu S, Yellapantula V, et al. Waldenstr\u00f6m macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations. Blood Adv. 2022;7:971\u201381.","journal-title":"Blood Adv"},{"key":"1579_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/sonc.2003.50074","volume":"30","author":"JF San Miguel","year":"2003","unstructured":"San Miguel JF, Vidriales MB, Ocio E, Mateo G, S\u00e1nchez-Guijo F, S\u00e1nchez ML, et al. Immunophenotypic analysis of Waldenstrom\u2019s macroglobulinemia. Semin Oncol. 2003;30:187\u201395.","journal-title":"Semin Oncol"},{"key":"1579_CR33","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/ajh.27666","volume":"100","author":"MA Gertz","year":"2025","unstructured":"Gertz MA. Waldenstr\u00f6m Macroglobulinemia: 2025 Update on Diagnosis, Risk Stratification, and Management. Am J Hematol. 2025;100:1061\u201373.","journal-title":"Am J Hematol"},{"key":"1579_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104856","volume":"25","author":"JH Lim","year":"2022","unstructured":"Lim JH, Wang JQ, Webb F, Saxena K, Enosi Tuipulotu D, Pandey A, et al. Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenstr\u00f6m macroglobulinemia. iScience. 2022;25:104856.","journal-title":"iScience"},{"key":"1579_CR35","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3324\/haematol.2017.172718","volume":"102","author":"M Varettoni","year":"2017","unstructured":"Varettoni M, Zibellini S, Defrancesco I, Ferretti VV, Rizzo E, Malcovati L, et al. Pattern of somatic mutations in patients with Waldenstr\u00f6m macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. Haematologica. 2017;102:2077\u201385.","journal-title":"Haematologica"},{"key":"1579_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.18502","volume":"200","author":"DF Moreno","year":"2023","unstructured":"Moreno DF, L\u00f3pez-Guerra M, Paz S, Oliver-Cald\u00e9s A, Mena M, Correa JG, et al. Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstr\u00f6m macroglobulinaemia. Br J Haematol. 2023;200:187\u201396.","journal-title":"Br J Haematol"},{"key":"1579_CR37","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.050227","volume":"16","author":"R Garc\u00eda-Sanz","year":"2023","unstructured":"Garc\u00eda-Sanz R, Garc\u00eda-\u00c1lvarez M, Medina A, Askari E, Gonz\u00e1lez-Calle V, Casanova M, et al. Clonal architecture and evolutionary history of Waldenstr\u00f6m\u2019s macroglobulinemia at the single-cell level. Dis Model Mech. 2023;16:dmm050227.","journal-title":"Dis Model Mech"},{"key":"1579_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00719-0","volume":"12","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV, Kumar S, Lonial S, Mateos MV. Smoldering multiple myeloma current treatment algorithms. Blood Cancer J. 2022;12:129.","journal-title":"Blood Cancer J"},{"key":"1579_CR39","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1182\/blood-2011-10-384768","volume":"119","author":"RA Kyle","year":"2012","unstructured":"Kyle RA, Benson JT, Larson DR, Therneau TM, Dispenzieri A, Kumar S, et al. Progression in smoldering Waldenstr\u00f6m macroglobulinemia: Long-term results. Blood. 2012;119:4462\u20136.","journal-title":"Blood"},{"key":"1579_CR40","first-page":"2950","volume":"12","author":"S Bal","year":"2022","unstructured":"Bal S, Kumar SK, Fonseca R, Gay F, Hungria VT, Dogan A, et al. Multiple myeloma with t(11;14): unique biology and evolving landscape. Am J Cancer Res. 2022;12:2950\u201365.","journal-title":"Am J Cancer Res"},{"key":"1579_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.92","volume":"5","author":"AM Rajan","year":"2015","unstructured":"Rajan AM, Rajkumar SV. Interpretation of cytogenetic results in multiple myeloma for clinical practice. Blood Cancer J. 2015;5:e365.","journal-title":"Blood Cancer J"},{"key":"1579_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3109\/10428194.2015.1061189","volume":"57","author":"K Jamani","year":"2016","unstructured":"Jamani K, Duggan P, Neri P, Bahlis N, Jimenez-Zepeda VH. Co-existent B-cell and plasma cell neoplasms: a case series providing novel clinical insight. Leuk Lymphoma. 2016;57:557\u201362.","journal-title":"Leuk Lymphoma"},{"key":"1579_CR43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s002770100328","volume":"80","author":"H Kaufmann","year":"2001","unstructured":"Kaufmann H, Ackermann J, N\u00f6sslinger T, Kr\u00f6mer E, Zojer N, Schreiber S, et al. Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma - A report on two cases. Ann Hematol. 2001;80:474\u20138.","journal-title":"Ann Hematol"},{"key":"1579_CR44","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1182\/blood-2021-153320","volume":"138","author":"SL Slager","year":"2021","unstructured":"Slager SL, Parikh SA, Achenbach SJ, Kleinstern G, Boddicker NJ, Norman AD, et al. Prevalence and overall survival of low count monoclonal B-Cell Lymphocytosis (LC-MBL): a screening study of 8,297 individuals from the Mayo Clinic Biobank. Blood. 2021;138:2632.","journal-title":"Blood"},{"key":"1579_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood-2009-01-197368","volume":"114","author":"WG Nieto","year":"2009","unstructured":"Nieto WG, Almeida J, Romero A, Teodosio C, L\u00f3pez A, Henriques AF, et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood. 2009;114:33\u20137.","journal-title":"Blood"},{"key":"1579_CR46","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood.2021012890","volume":"139","author":"PM Kolijn","year":"2022","unstructured":"Kolijn PM, Hosnijeh FS, Sp\u00e4th F, Hengeveld PJ, Agathangelidis A, Saleh M, et al. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 2022;139:1557\u201363.","journal-title":"Blood"},{"key":"1579_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70046","volume":"8","author":"S R\u00f6gnvaldsson","year":"2024","unstructured":"R\u00f6gnvaldsson S, \u00d3skarsson J\u00de, Thorsteinsd\u00f3ttir S, Hultcrantz M, Palmason R, Sverrisdottir IS, et al. Monoclonal gammopathy of undetermined significance with multiple paraproteins: a population-based screening study. HemaSphere. 2024;8:e70046.","journal-title":"HemaSphere"},{"key":"1579_CR48","unstructured":"Rodriguez S, Celay J, Goicoechea I, Jimenez C, Botta C, Garcia-Barchino MJ, et al. Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. Sci Adv. 8:eabl4644."},{"key":"1579_CR49","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/2643-3230.BCD-21-0043","volume":"2","author":"A Kaushal","year":"2021","unstructured":"Kaushal A, Nooka AK, Carr AR, Pendleton KE, Barwick BG, Manalo J, et al. Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation, and MyD88-mutant progenitors precede Waldenstrom macroglobulinemia. Blood Cancer Discov. 2021;2:600\u201315.","journal-title":"Blood Cancer Discov"},{"key":"1579_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1643615","volume":"16","author":"TF Tang","year":"2025","unstructured":"Tang TF, Chan YT, Lim HJ, Cheok YY, Anuar NA, Cheong CS, et al. RUNX1 expression dynamics in plasma cell differentiation and pathogenesis of multiple myeloma. Front Immunol. 2025;16:1643615.","journal-title":"Front Immunol"},{"key":"1579_CR51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/bjh.15560","volume":"184","author":"JN Gustine","year":"2019","unstructured":"Gustine JN, Tsakmaklis N, Demos MG, Kofides A, Chen JG, Liu X, et al. TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenstr\u00f6m macroglobulinaemia. Br J Haematol. 2019;184:242\u20135.","journal-title":"Br J Haematol"},{"key":"1579_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70525","volume":"13","author":"A Trojani","year":"2024","unstructured":"Trojani A, Beghini A, Bossi LE, Stefanucci MR, Palumbo C, Greco A, et al. Mutational landscape of bone marrow CD19 and CD138 cells in Waldenstr\u00f6m Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS). Cancer Med. 2024;13:e70525.","journal-title":"Cancer Med"},{"key":"1579_CR53","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1200\/JCO.19.02314","volume":"38","author":"SP Treon","year":"2020","unstructured":"Treon SP, Xu L, Guerrera ML, Jimenez C, Hunter ZR, Liu X, et al. Genomic landscape of Waldenstr\u00f6m macroglobulinemia and its impact on treatment strategies. J Clin Oncol. 2020;38:1198\u2013208.","journal-title":"J Clin Oncol"},{"key":"1579_CR54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/bjh.13897","volume":"172","author":"L Xu","year":"2016","unstructured":"Xu L, Hunter ZR, Tsakmaklis N, Cao Y, Yang G, Chen J, et al. Clonal architecture of CXCR4 WHIM-like mutations in Waldenstr\u00f6m Macroglobulinaemia. Br J Haematol. 2016;172:735\u201344.","journal-title":"Br J Haematol"},{"key":"1579_CR55","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3324\/haematol.2017.163766","volume":"102","author":"A Mikulasova","year":"2017","unstructured":"Mikulasova A, Wardell CP, Murison A, Boyle EM, Jackson GH, Smetana J, et al. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma. Haematologica. 2017;102:1617\u201325.","journal-title":"Haematologica"},{"key":"1579_CR56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","volume":"132","author":"BA Walker","year":"2018","unstructured":"Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018;132:587\u201397.","journal-title":"Blood"},{"key":"1579_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41375-018-0206-x","volume":"33","author":"AK Dutta","year":"2019","unstructured":"Dutta AK, Fink JL, Grady JP, Morgan GJ, Mullighan CG, To LB, et al. Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability. Leukemia. 2019;33:457\u201368.","journal-title":"Leukemia"},{"key":"1579_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01053-3","volume":"14","author":"A Medina-Herrera","year":"2024","unstructured":"Medina-Herrera A, Vazquez I, Cuenca I, Rosa-Rosa JM, Ariceta B, Jimenez C, et al. The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood Cancer J. 2024;14:74.","journal-title":"Blood Cancer J"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01579-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01579-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01579-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:03:36Z","timestamp":1791907416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01579-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01579-8","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SR received honoraria for scientific talks from Siemens Healthineers, Johnson & Johnson. S\u00de, received honoraria for scientific talks from Abbvie, Thermo Fisher. SYK, received research funding from Amgen and Celgene; Independent Data Monitoring Committee for Jansen. SH is currently employed by The Binding Site. OPE, JF-M, J\u00deO, LS-F, JP, QL, SM, ERR, TJL, BD and AO declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All subjects enrolled in this study provided their informed consent to participate according to the Declaration of Helsinki. The study was approved by the Icelandic National Bioethics Committee (NCT03327597), and the Icelandic Data Protection Agency. Permission for transfer of all biological samples for this study (Registration number: 2020\/252) was granted by the Spanish Ministry of Health.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"181"}}